179 related articles for article (PubMed ID: 23883603)
1. The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease.
White AA; Bosso JV; Stevenson DD
Allergy Asthma Proc; 2013; 34(4):378-382. PubMed ID: 23883603
[TBL] [Abstract][Full Text] [Related]
2. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
Waldram JD; Simon RA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
[TBL] [Abstract][Full Text] [Related]
3. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
4. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
Simon RA
Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
[TBL] [Abstract][Full Text] [Related]
5. Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs.
Laidlaw TM; Cahill KN
J Allergy Clin Immunol Pract; 2017; 5(3):537-545. PubMed ID: 28483309
[TBL] [Abstract][Full Text] [Related]
6. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
[TBL] [Abstract][Full Text] [Related]
7. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization.
Walters KM; Simon RA; Woessner KM; Wineinger NE; White AA
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):71-76. PubMed ID: 28668243
[TBL] [Abstract][Full Text] [Related]
8. Aspirin desensitization in aspirin-exacerbated respiratory disease.
White AA; Stevenson DD
Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
[TBL] [Abstract][Full Text] [Related]
9. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
Shaker M; Lobb A; Jenkins P; O'Rourke D; Takemoto SK; Sheth S; Burroughs T; Dykewicz MS
J Allergy Clin Immunol; 2008 Jan; 121(1):81-7. PubMed ID: 17716716
[TBL] [Abstract][Full Text] [Related]
11. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease.
Kowalski ML; Wardzyńska A; Makowska JS
Immunol Allergy Clin North Am; 2016 Nov; 36(4):705-717. PubMed ID: 27712765
[TBL] [Abstract][Full Text] [Related]
12. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
13. Frequency and severity of reactions to a 325-mg aspirin dose during desensitization.
Schuler CF; Baldwin JL; Baptist AP
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):333-338.e1. PubMed ID: 28065801
[TBL] [Abstract][Full Text] [Related]
14. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
15. The role of aspirin desensitization in the management of aspirin-exacerbated respiratory disease.
Tajudeen BA; Schwartz JS; Bosso JV
Curr Opin Otolaryngol Head Neck Surg; 2017 Feb; 25(1):30-34. PubMed ID: 27849653
[TBL] [Abstract][Full Text] [Related]
16. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
[TBL] [Abstract][Full Text] [Related]
17. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
Waldram J; Walters K; Simon R; Woessner K; Waalen J; White A
J Allergy Clin Immunol; 2018 Jan; 141(1):250-256. PubMed ID: 28550988
[TBL] [Abstract][Full Text] [Related]
18. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
[No Abstract] [Full Text] [Related]
19. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302.
Esmaeilzadeh H; Nabavi M; Aryan Z; Amirzargar AA
Expert Rev Respir Med; 2015 Oct; 9(5):511-8. PubMed ID: 26366802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
